Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Source:http://linkedlifedata.com/resource/pubmed/id/18981464

J. Clin. Oncol. 2008 Dec 1 26 34 5569-75

Download in:

View as

General Info

PMID
18981464